Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022

Critical Care

  • Managing right ventricular failure in the setting of pulmonary embolism
    You have access
    Managing right ventricular failure in the setting of pulmonary embolism
    Sharmeen Sorathia, MD, Anibelky Almanzar, MD, Abhishek Bhandiwad, MD and Phoo Pwint Nandar, MD
    Cleveland Clinic Journal of Medicine May 2025, 92 (5) 301-309; DOI: https://doi.org/10.3949/ccjm.92a.24069

    The authors review current management strategies, including medical, percutaneous interventional, and surgical options, and discuss recent advances in the field.

  • You have access
    How can I better recognize and manage delirium in my hospitalized patients?
    Amanda Pomerantz, DO, Anna P. Shapiro-Krew, MD and Andrew Coulter, MD, MA
    Cleveland Clinic Journal of Medicine January 2025, 92 (1) 17-20; DOI: https://doi.org/10.3949/ccjm.92a.24048

    By knowing common precipitants and mimickers of delirium and considerations for workup, clinicians can implement nonpharmacologic preventive strategies, better identify patients experiencing delirium, and optimize symptom management.

  • You have access
    Shortness of breath in a 52-year-old man with HIV and severe mitral regurgitation
    Felix Wangmang, MD, PharmD, Achilles Aiken, MD and Kuang-Yuh Chyu, MD, PhD
    Cleveland Clinic Journal of Medicine January 2025, 92 (1) 23-30; DOI: https://doi.org/10.3949/ccjm.92a.24060

    The patient presented with 3 weeks of acute on chronic dyspnea on exertion with progression to dyspnea at rest and associated orthopnea.

  • You have access
    What fluids should I order for my patient with acute pancreatitis?
    Anusha Agarwal, MD, Arjun Chatterjee, MD and Prabhleen Chahal, MD
    Cleveland Clinic Journal of Medicine August 2024, 91 (8) 466-468; DOI: https://doi.org/10.3949/ccjm.91a.24027

    Recent data show that moderate fluid resuscitation is associated with fewer adverse events and that lactated Ringer’s may be superior to normal saline.

  • You have access
    Do patients with sepsis benefit from intravenous albumin?
    Ryan Dunn, MD, Kealy Ham, MD, Lisa Marks, MLS, AHIP and Neera Agrwal, MD, PhD
    Cleveland Clinic Journal of Medicine July 2024, 91 (7) 405-407; DOI: https://doi.org/10.3949/ccjm.91a.23089

    Patients with sepsis who do not need vasopressors do not benefit from intravenous albumin compared with intravenous crystalloid therapy alone.

  • You have access
    Does my patient with acute variceal hemorrhage need a transjugular intrahepatic portosystemic shunt?
    Mahnur Haider, MD, Indira Bhavsar-Burke, MD, Robert S. O’Shea, MD, MSCE and Christina C. Lindenmeyer, MD
    Cleveland Clinic Journal of Medicine July 2024, 91 (7) 409-413; DOI: https://doi.org/10.3949/ccjm.91a.24014

    Placement of a transjugular intrahepatic portosystemic shunt can be used as salvage therapy to control bleeding when endoscopic management fails and as a means of secondary prophylaxis in select patients.

  • You have access
    Do I always need a central venous catheter to administer vasopressors?
    Zainab J. Gandhi, MD, Siddharth Dugar, MD, FCCP, FCCM, FASE and Ryota Sato, MD, EDIC
    Cleveland Clinic Journal of Medicine May 2024, 91 (5) 287-291; DOI: https://doi.org/10.3949/ccjm.91a.23033

    Although generally preferred, central venous catheters carry risks such as procedural complications, infection, and thrombosis. Clinicians must assess, case by case, whether a peripheral intravenous catheter can be used.

  • You have access
    What is the role for terlipressin in hepatorenal syndrome?
    Stephanie N. Bass, PharmD, Aanchal Kapoor, MD and Christina C. Lindenmeyer, MD
    Cleveland Clinic Journal of Medicine November 2023, 90 (11) 664-667; DOI: https://doi.org/10.3949/ccjm.90a.23037

    The drug is recommended as a first-line treatment of hepatorenal syndrome-related acute kidney injury, but it is associated with respiratory failure, especially in the setting of albumin administration, and certain comorbidities may increase the risk.

  • You have access
    COVID-19: A management update
    Kathryn Bash, MHSc, MSN, APRN-CNP, Gretchen Sacha, PharmD, BCCCP and Mani Latifi, MD
    Cleveland Clinic Journal of Medicine November 2023, 90 (11) 677-683; DOI: https://doi.org/10.3949/ccjm.90a.22102

    The authors examine current guidelines of the Infectious Diseases Society of America and the National Institutes of Health.

  • You have access
    Should midodrine be used as an intravenous vasopressor-sparing agent in septic shock?
    Simran Gupta, MD, Ayan Sen, MD and Aman Verma, DO
    Cleveland Clinic Journal of Medicine October 2023, 90 (10) 603-605; DOI: https://doi.org/10.3949/ccjm.90a.23040

    Research and robust data are still lacking regarding use of midodrine in this setting.

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Adolescent Medicine
  • Allergy/Immunology
  • Anticoagulation
  • Cardiology
  • Covid-19
  • Critical Care
  • Dermatology
  • Diabetes
  • Drug Therapy
  • Electrophysiology
  • Emergency Medicine
  • Endocrinology
  • Family Medicine
  • Gastroenterology
  • Genetics
  • Geriatrics
  • Hematology
  • Hepatology
  • Hospice & Palliative Medicine
  • Hospital Medicine
  • Imaging
  • Infectious Diseases
  • Medical Humanities
  • Medical Humanities/Ethics
  • Men's Health
  • Mental Health
  • Nephrology
  • Neurology
  • Obesity
  • Oncology
  • Pain
  • Physical Exam
  • Practice Management
  • Preventive Care
  • Pulmonology
  • Rehabilitation Medicine
  • Rheumatology
  • Sleep Medicine
  • Surgery/Surgery Subspecialties
  • Vascular Medicine
  • Women's Health

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2025 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire